Skip to search formSkip to main contentSkip to account menu

APC 8024

Known as: APC8024 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Lapuleucel-T

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
Antigen presenting cell based immunotherapy targeting HER2/Neu positive solid tumors: Results of a phase 1 study of APC8024.
2528 Background: APC8024 is a cellular vaccine therapy derived from autologous antigen (Ag) presenting cells (APC) loaded ex vivo… 
2001
2001
Dendritic cell-based treatment of cancer: closing in on a cellular therapy.
PURPOSE Dendritic cells are the most potent antigen-presenting cells and are critical to initiation of immune responses… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)